Benzinga·5h ago·Vandana SinghAbbott Labs Beats Q1 But Slashes 2026 Guidance, Stock Tumbles 4.76%Abbott Labs beat Q1 earnings but slashed full-year guidance, causing stock to plummet 4.76% to 52-week low of $96.72. ABTstock declineearnings beat
Benzinga··Vandana Singh